171 related articles for article (PubMed ID: 22630573)
21. Muir-Torre syndrome.
Cohen PR; Kohn SR; Davis DA; Kurzrock R
Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655
[TBL] [Abstract][Full Text] [Related]
22. Glioblastoma multiforme in the Muir-Torre syndrome.
Binder ZA; Johnson MW; Joshi A; Hann CL; Griffin CA; Olivi A; Riggins GJ; Gallia GL
Clin Neurol Neurosurg; 2011 Jun; 113(5):411-5. PubMed ID: 21288634
[TBL] [Abstract][Full Text] [Related]
23. A Muir-Torre syndrome family.
Serleth HJ; Kisken WA
Am Surg; 1998 Apr; 64(4):365-9. PubMed ID: 9544152
[TBL] [Abstract][Full Text] [Related]
24. MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms.
Morales-Burgos A; Sánchez JL; Figueroa LD; De Jesús-Monge WE; Cruz-Correa MR; González-Keelan C; Nazario CM
P R Health Sci J; 2008 Dec; 27(4):322-7. PubMed ID: 19069357
[TBL] [Abstract][Full Text] [Related]
25. [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis].
Doré MX; Dieumegard B; Grandjouan S; Avril MF; Martinet C; Ducreux M; Lasser P; Bressac-de Paillerets B
Ann Dermatol Venereol; 1999; 126(8-9):582-6. PubMed ID: 10530344
[TBL] [Abstract][Full Text] [Related]
26. Eyelid sebaceous carcinoma associated with Muir-Torre syndrome in two cases.
Demirci H; Nelson CC; Shields CL; Eagle RC; Shields JA
Ophthalmic Plast Reconstr Surg; 2007; 23(1):77-9. PubMed ID: 17237705
[TBL] [Abstract][Full Text] [Related]
27. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions.
Marazza G; Masouyé I; Taylor S; Prins C; Gaudin T; Saurat JH; French LE
Arch Dermatol; 2006 Aug; 142(8):1039-42. PubMed ID: 16924054
[TBL] [Abstract][Full Text] [Related]
28. DNA image cytometry in sebaceous tumours of the Muir-Torre syndrome.
Kiehl P; Richter K; Erdelkamp J; Herbst RA; Kapp A; Böcking A
Br J Dermatol; 1998 Apr; 138(4):706-8. PubMed ID: 9640386
[No Abstract] [Full Text] [Related]
29. The genetic basis of Muir-Torre syndrome includes the hMLH1 locus.
Bapat B; Xia L; Madlensky L; Mitri A; Tonin P; Narod SA; Gallinger S
Am J Hum Genet; 1996 Sep; 59(3):736-9. PubMed ID: 8751876
[No Abstract] [Full Text] [Related]
30. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
Abbas O; Mahalingam M
J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
[TBL] [Abstract][Full Text] [Related]
31. Muir-Torre syndrome and early detection of internal malignancy.
Chen CS; Loweinstein L; James C; Huilgol SC; Selva D
Med J Aust; 2003 Apr; 178(8):368. PubMed ID: 12776718
[No Abstract] [Full Text] [Related]
32. [Facial sebaceous carcinoma: Muir-Torre syndrome].
Arias-Santiago S; Soriano Hernández MI; Aneiros-Fernández J; Gutiérrez Salmerón MT; Aneiros Cachaza J; Naranjo Sintes R
Med Clin (Barc); 2010 Jul; 135(6):291. PubMed ID: 19833357
[No Abstract] [Full Text] [Related]
33. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome.
Peris K; Onorati MT; Keller G; Magrini F; Donati P; Muscardin L; Höfler H; Chimenti S
Br J Dermatol; 1997 Sep; 137(3):356-60. PubMed ID: 9349329
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome.
Entius MM; Keller JJ; Drillenburg P; Kuypers KC; Giardiello FM; Offerhaus GJ
Clin Cancer Res; 2000 May; 6(5):1784-9. PubMed ID: 10815898
[TBL] [Abstract][Full Text] [Related]
35. Sebaceous gland adenoma of the tarsal conjunctiva in a patient with Muir-Torre syndrome.
Font RL; Rishi K
Ophthalmology; 2003 Sep; 110(9):1833-6. PubMed ID: 13129885
[TBL] [Abstract][Full Text] [Related]
36. A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene.
Vernez M; Hutter P; Monnerat C; Halkic N; Gugerli O; Bouzourene H
Fam Cancer; 2007; 6(1):141-5. PubMed ID: 17051350
[TBL] [Abstract][Full Text] [Related]
37. Biallelic MYH germline mutations as cause of Muir-Torre syndrome.
Guillén-Ponce C; Castillejo A; Barberá VM; Pascual-Ramírez JC; Andrada E; Castillejo MI; Guarinós C; Molina-Garrido MJ; Carrato A; Soto JL
Fam Cancer; 2010 Jun; 9(2):151-4. PubMed ID: 19998059
[TBL] [Abstract][Full Text] [Related]
38. Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis.
Southey MC; Young MA; Whitty J; Mifsud S; Keilar M; Mead L; Trute L; Aittomäki K; McLachlan SA; Debinski H; Venter DJ; Armes JE
Am J Surg Pathol; 2001 Jul; 25(7):936-41. PubMed ID: 11420466
[TBL] [Abstract][Full Text] [Related]
39. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
[TBL] [Abstract][Full Text] [Related]
40. [Torre-Muir syndrome. Sebaceous gland tumors indicate colon carcinoma and other internal malignant tumors].
Karsten U; Christophers E; Sterry W
Dtsch Med Wochenschr; 1987 Aug; 112(34):1296-301. PubMed ID: 3622267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
